Skip to main content

Opening Day: Passage Goes Public Amid Coronavirus-Related Stock Market Meltdown

Passage Bio went public during the stock market's worst week since 2008. Nonetheless, the company did fine, with the stock jumping 20% in its first day trading and the offering bringing in $216 million for the gene therapy company.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.